专利检索 ap:("PFIZER INC." OR "RINAT NEUROSCIENCE CORP.") AND inv:"ASHWIN GOLLERKERI" 第 1 页

1.

发明申请
TREATMENT WITH ANTI-EFNA4 ANTIBODY-DRUG CONJUGATES 审中-公开

公开(公告)号：US20180099054A1

公开(公告)日：2018-04-12

申请号：US15573303

申请日：2016-05-12

申请人： PFIZER INC. , RINAT NEUROSCIENCE CORP.

发明人： ASHWIN GOLLERKERI , KAREN VELASTEGUI , RAFFAELE BAFFA , JAYMES SCOT HOLLAND

IPC分类号： A61K47/50 , C07K16/28 , A61P35/00 , A61K48/00

CPC分类号： A61K47/50 , A61K47/6809 , A61K47/6849 , A61K48/0083 , A61K2039/505 , A61P35/00 , C07K16/28 , C07K2317/53 , C07K2317/565 , C07K2317/77 , C07K2317/92

摘要： The present invention provides for dosing regimens for the treatment of patients with cancer and/or an EFNA4-associated disorder with an anti-EFNA4 antibody-drug conjugate (ADC). The present invention further provides for methods for the treatment of patients with cancer and/or an EFNA4-associated disorder in which an anti-EFNA4 ADC is administered intravenously weekly (QW) or every 3 weeks (Q3W).